“…The results of numerous studies indicate that obese humans demonstrate ∼50-100% higher levels of MSNA compared with their non-obese peers (Spraul et al, 1993, Scherrer et al, 1994, Spraul et al, 1994, Gudbjornsdottir et al, 1996, Grassi et al, 2000, Weyer et al, 2000, Alvarez et al, 2002. In contrast, Hugget et al (Huggett et al, 2005) reported that MSNA was not elevated in overweight individuals. The reason(s) for this apparent discrepancy is not entirely clear but could be due, in part, to the selection of a group of overweight subjects with a primarily subcutaneous obese phenotype (see below under "6.…”